Abstract
Etiology, Clinical Features, and Treatment Outcomes of Patients with Acute Pancreatitis: A 5-Year Experience at the Philippine General Hospital
Tristan Paulo Madrigal, MD; Aldrich Ivan Lois Burog, MD; Emilio Villanueva III, MD; Eric Yasay, MD
University of the Philippines - Philippine General Hospital
Significance: The global incidence of acute pancreatitis has increased over the past decade, but data in the Philippines remain limited, with the latest local study conducted before the Atlanta classification.
Methodology: A retrospective cohort study was conducted at a tertiary hospital in the Philippines, involving adult patients with acute pancreatitis admitted from January 2019 to December 2023. The primary outcome was in-hospital mortality, with secondary outcomes including predictors of mortality, organ failure, and underlying etiologies. A minimum sample size of 385 participants was computed.
Results: In total, 409 patients were included in the study, with a mean age of 47.35 ± 16.29 years and 48.17% being males. The severity of acute pancreatitis was mild in 60.9%, moderately severe in 10.2%, and severe in 28.9%. The most common etiology was gallstone (67.96%) followed by alcohol (23.23%) and infections (4.89%). The in-hospital mortality rate was 13.2%, rising to 35.15% for necrotizing pancreatitis. Renal failure was the most common organ involvement at 26.16%. Multivariate analysis identified older age (OR: 1.04), alcohol etiology (OR: 2.48), necrotizing subtype (OR: 4.00), higher Modified Marshall score (OR: 1.26), longer duration of symptoms before presentation (OR: 1.27), and lower serum albumin levels (OR: 0.46) as predictors of mortality.
Conclusion: Acute pancreatitis is associated with significant morbidity and mortality, particularly in patients with severe disease. Gallstone disease is the most common identified etiology, followed by alcohol and infections. Utilizing clinical predictors may identify patients who require aggressive resuscitation to reduce the risk of death.
Important Dates to Remember
JRRE Activities 2023-2024 |
Proposed Dates |
---|---|
Resumption of face-to-face Evidence-Based Medicine Workshop Venue to be announced once finalized. |
July 21, 2023 (Friday), 1-5pm |
Monthly Critical Appraisal of Topics Conferences to be gaciliated by Research Coordinators per Institution | Monthly Critical Appraisal of Topics Conferences per Institution |
CAT Plenary/Liver Con Dates: September 23, 2023 December 16, 2023 March 2024 (During the JAC) Resumption of face-to-face Quarterly Critical Appraisal of Topics facilitated by the JRRE |
2 Clinical scenarios and articles are to be sent to institutions each on August 2023, November 2023, and February 2024; |
Hybrid Research Workshop 4 week asynchronous via Moodle, followed by a 1 day on-site Onsite Workshop Research Protocol Presentation for Level I GI Fellows-In-Training - Research Protocol Presentation: August 12, 2023 - Research Forums of the Tripartite Societies |
Week 1: July 15-21, 2023 Week 2: July 22-28, 2023 Week 3: July 29-August 4, 2023 Week 4: August 5-11, 2023 |
Research Manuscript Workshop for level II GI Fellows-In-Training | January 6, 2024 |